# Pre-hospital Administration of Lyophilized Plasma for Post-traumatic Coagulopathy Treatment (PREHO-PLYO)

> **NCT02736812** · PHASE3 · COMPLETED · sponsor: **French Defence Health Service** · enrollment: 140 (actual)

## Conditions studied

- Shock Hemorrhagic

## Interventions

- **BIOLOGICAL:** French Lyophilized Plasma
- **BIOLOGICAL:** Normale Saline Solution

## Key facts

- **NCT ID:** NCT02736812
- **Lead sponsor:** French Defence Health Service
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-04-01
- **Primary completion:** 2019-10-31
- **Final completion:** 2019-11-30
- **Target enrollment:** 140 (ACTUAL)
- **Last updated:** 2020-01-07

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02736812

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02736812, "Pre-hospital Administration of Lyophilized Plasma for Post-traumatic Coagulopathy Treatment (PREHO-PLYO)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02736812. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*